Abstract
Introduction: chikungunya fever is a re-emerging viral infection, which presents a great variety of lesions on the skin and mucous membranes. We describe the case of a child with confirmed Chikungunya virus infection who, during his evolution, presented extensive and severe vesiculo-bullous and maculo- purpuric lesions.
Clinical Case: a 6-year-old male patient consulted for high fever, generalized maculo-papular rash, and severe arthralgia that made walking difficult. Physical examination revealed a generalized erythematous rash on the chest and abdomen with islands of normal skin, similar to that observed in dengue virus infection, in addition to purpuric and large vesiculo-bullous lesions filled with abundant serous fluid in the upper and lower limbs. Ulcerative lesions such as canker sores on the tongue, and marked palmoplantar desquamation. He received immunoglobulin 400 mg/kg/day for 5 days and methylprednisolone 30 mg/kg single dose, the blisters were debrided. Excellent evolution. Serology: negative Elisa test for Dengue. Chikungunya IgM: positive.
Discussion: vesiculo-bullous and purpuric macules are rare and atypical lesions as an unusual manifestation of Chikungunya virus infection, simulating Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis, erythema multiforme, and autoimmune bullous diseases. The classic clinical picture of the disease does not include the observation of these lesions, which constitute a diagnostic challenge. They have been observed in neonates, young infants, and rarely in adults, as well as ulcerative lesions on the tongue such as canker sores and marked palmoplantar desquamation, rarely described in Chikungunya fever.
Conclusions: this atypical and severe case suggests the inclusion of Chikungunya in the differential diagnosis of bullous febrile dermatosis.
References
Robinson MC. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features. Trans R Soc Trop Med Hyg 1955; 49(1):28-32. doi: 10.1016/0035-9203(55)90080-8.
Petitdemange C, Wauquier N, Vieillard V. Control of immunopathology during chikungunya virus infection. J Allergy Clin Immunol 2015; 135(4):846-55. doi: 10.1016/j.jaci.2015.01.039.
van Duijl M, Hoornweg T, Rodenhuis I, Smit J. Early events in Chikungunya virus infection-from virus cell binding to membrane fusion. Viruses 2015; 7(7):3647-74. doi: 10.3390/v7072792.
Leparc I, Nougairede A, Cassadou S, Prat C, de Lamballerie X. Chikungunya in the Américas. Lancet 2014; 383(9916):514. doi: 10.1016/S0140-6736(14)60185-9.
Torres J, Leopoldo G, Castro J, Rodríguez L, Saravia V, Arvelaez J, et al. Chikungunya fever: atypical and lethal cases in the Western hemisphere: a Venezuelan experience. IDCases 2014; 2(1):6-10. doi: 10.1016/j.idcr.2014.12.002.
Petersen L, Powers AM. Chikungunya: epidemiology (version 1; referees: 2 approved) F1000Research 2016, 5(F1000 FacultyRev):82 doi: 10.12688/f1000research.7171.1.
López G. Fiebre chikungunya en Venezuela. Arch Venez Puer Ped 2014;77(4):161. Disponible en: http://ve.scielo.org/scielo.php?script=sci_arttext&pid=S0004-06492014000400001&lng=es.
Teo T, Her Z, Tan J, Lum F, Lee W, Chan Y, et al. Caribbean and La Réunion Chikungunya virus isolates differ in their capacity to induce proinflammatory Th1 and NK cell responses and acute joint pathology. J Virol 2015; 89(15):7955-69. doi: 10.1128/JVI.00909-15.
Pohjala L, Utt A, Varjak M, Lulla A, Merits A, Ahola T, et al. Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays. PLoS One 2011; 6(12):e28923. doi: 10.1371/journal.pone.0028923.
Hochedez P, Jaureguiberry S, Debruyne M, Bossi P, Hausfater P, Brucker G, et al. Chikungunya infection in travelers. Emerg Infect Dis 2006; 12(10):1565-7. doi: 10.3201/eid1210.060495.
Garg T, Sanke S, Ahmed R, Chander R, Basu S. Stevens-Johnson syndrome and toxic epidermal necrolysis-like cutaneous presentation of chikungunya fever: a case series. Pediatr Dermatol 2018; 35(3):392-6. doi: 10.1111/pde.13450.
Chahar H, Bharaj P, Dar L, Guleria R, Kabra S, Broor S. Co-infections with chikungunya virus and dengue virus in Delhi, India. Emerg Infect Dis 2009; 15(7):1077-80. doi: 10.3201/eid1507.080638.
Nimmannitya S, Halstead S, Cohen S, Margiotta M. Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever. Am J Trop Med Hyg 1969; 18(6):954-71. doi: 10.4269/ajtmh.1969.18.954.
Organización Panamericana de la Salud. Dengue: guías de atención para enfermos en la región de las Américas. La Paz: OPS, 2010.
Kumar A, Best C, Benskin G. Epidemiology, clinical and laboratory features and course of Chikungunya among a cohort of children during the first caribbean epidemic. J Trop Pediatr 2017; 63(1):43-9. doi: 10.1093/tropej/fmw051.
Bandyopadhyay D, Ghosh S. Mucocutaneous manifestations of Chikungunya fever. Indian J Dermatol 2010;55(1):64-7. doi: 10.4103/0019-5154.60356.
Morrison J. Chikungunya fever. Int J Dermatol 1979; 18(8):628-9. doi: 10.1111/j.1365-4362.1979.tb04677.x.
Inamadar A, Palit A, Sampagavi V, Raghunath S, Deshmukh N. Cutaneous manifestations of chikungunya fever: observations made during a recent outbreak in south India. Int J Dermatol 2008; 47(2):154-9. doi: 10.1111/j.1365-4632.2008.03478.x.
Valamparampil J, Chirakkarot S, Letha S, Jayakumar C, Gopinathan K. Clinical profile of Chikungunya in infants. Indian J Pediatr 2009; 76(2):151-5. doi: 10.1007/s12098-009-0045-x.
Pakran J, George M, Riyaz N, Arakkal R, George S, Rajan U, et al. Purpuric macules with vesiculobullous lesions: a novel manifestation of Chikungunya. Int J Dermatol 2011; 50(1):61-9. doi: 10.1111/j.1365-4632.2010.04644.x.
Pilania R, Bhattarai D, Singh S. Controversies in diagnosis and management of Kawasaki disease. World J Clin Pediatr 2018; 7(1):27-35. doi: 10.5409/wjcp.v7.i1.27.
Seetharam K, Sridevi K, Vidyasagar P. Cutaneous manifestations of chikungunya fever. Indian Pediatr 2012; 49(1):51-3. doi: 10.1007/s13312-012-0007-7.
Singh N, Chandrashekar L, Konda D, Thappa D, Srinivas B, Dhodapkar R. Vesiculobullous viral exanthem due to chikungunya in an infant. Indian Dermatol Online J 2014; 5(Suppl 2):S119-20. doi: 10.4103/2229-5178.146188.
Riyaz N, Riyaz A, Rahima, Abdul Latheef E, Anitha P, Aravindan K, et al. Cutaneous manifestations of chikungunya during a recent epidemic in Calicut, north Kerala, south India. Indian J Dermatol Venereol Leprol 2010; 76(6):671-6. doi: 10.4103/0378-6323.72466.
Robin S, Ramful D, Zettor J, Benhamou L, Jaffar M, Rivière J, et al. Severe bullous skin lesions associated with Chikungunya virus infection in small infants. Eur J Pediatr 2010; 169(1):67-72. doi: 10.1007/s00431-009-0986-0.
Muñoz C, Castillo J, Salas D, Valderrama M, Rangel C, Vargas H, et al. Manifestaciones mucocutáneas atípicas por fiebre por el virus del chikungunya en neonatos y lactantes de Cúcuta, Los Patios y Villa del Rosario, Norte de Santander, Colombia, 2014. Biomédica 2016; 36(3):368-77. doi: 10.7705/biomedica.v36i3.2760.
Beserra F, Oliveira G, Marques T, Farias L, Santos J, Daher E, et al. Clinical and laboratory profiles of children with severe chikungunya infection. Rev Soc Bras Med Trop 2019; 52:e20180232. doi: 10.1590/0037-8682-0232-2018.
Paller A, Mancini A. Bulluos disorders of chilhood. En: Paller A, Mancini A. Hurwitz clinical pediatric dermatology: a texbook of skin disorders of childhood and adolescence. 4 ed. Edinburgh: Elsevier, 2011:303-20.
Torres J, Córdova L, Saravia V, Arvelaez J, Castro J. Nasal skin necrosis: an unexpected new finding in severe Chikungunya fever. Clin Infect Dis 2016; 62(1):78-81. doi: 10.1093/cid/civ718.
Barr K, Vaidhyanathan V. Chikungunya in Infants and children: is pathogenesis increasing? Viruses 2019; 11(3):294. doi: 10.3390/v11030294.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Archives of Pediatrics of Uruguay